Specifically, researchers found that while prostate cancer survivors make up 20 percent of the total cancer survivorship population, but only 5 percent of current research projects focus specifically on prostate cancer survivors.
Researchers found that breast, colorectal, gynecologic and hematological cancers are also underrepresented in current cancer survivorship studies. Other key findings include the following:
• “Quality of life” as a specific research focus more than doubles that of prevention, early detection and late effects of treatment.
• The topics least likely to be studied include radiation effects, hot flashes and fertility.
• Researchers also found a recent shift to an observational approach as compared to interventional research, which is supported by clinical trials.
Related Articles on Hospital Oncology:
Costs for Medicare Cancer Patients Undergoing Chemotherapy Lower in Physician Offices
Memphis’ Methodist Healthcare, West Clinic Partner for Cancer Service Line
Breast Cancer Therapy Market Projected to Increase Marginally Over Next Decade
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
